当前位置：药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 报告期内： -格式:2020-5-3
NDC包装id： 市场分类： 活性成分： 持证企业：
 美国NDC复合药物数据库文件4843条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
Semaglutide
HUMAN COMPOUNDED DRUG
73013-9000
OurPharma LLC
2024-2
SEMAGLUTIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
73013-9000-3
Morphine Sulfate
HUMAN COMPOUNDED DRUG
73013-1073
OurPharma LLC
2024-2
MORPHINE SULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 mg/1 mL
73013-1073-1
Fentanyl Citrate
HUMAN COMPOUNDED DRUG
73013-1064
OurPharma LLC
2024-2
FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 ug/1 mL
73013-1064-1
Ketamine HCl
HUMAN COMPOUNDED DRUG
73013-2018
OurPharma LLC
2024-2
KETAMINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
25 mg/1 mL
73013-2018-1
fentanyl citrate, ropivacaine hydrochloride
HUMAN COMPOUNDED DRUG
73013-1048
OurPharma LLC
2024-2
FENTANYL CITRATE; ROPIVACAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 ug/1 mL; 2 mg/1 mL
73013-1048-1
fentanyl citrate, ropivacaine hydrochloride
HUMAN COMPOUNDED DRUG
73013-1047
OurPharma LLC
2024-2
FENTANYL CITRATE; ROPIVACAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 ug/1 mL; 1 mg/1 mL
73013-1047-1
fentanyl citrate, ropivacaine hydrochloride
HUMAN COMPOUNDED DRUG
73013-1055
OurPharma LLC
2024-2
FENTANYL CITRATE; ROPIVACAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 ug/1 mL; 2 mg/1 mL
73013-1055-1
Fentanyl Citrate
HUMAN COMPOUNDED DRUG
73013-1065
OurPharma LLC
2024-2
FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 ug/1 mL
73013-1065-1
Tropicamide 1%, Cyclopentolate 1%, Phenylephrine 2.5%
HUMAN COMPOUNDED DRUG
71266-8211
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
PHENYLEPHRINE HYDROCHLORIDE; CYCLOPENTOLATE HYDROCHLORIDE; TROPICAMIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
25 mg/1 mL; 10 mg/1 mL; 10 mg/1 mL
71266-8211-1
Phenylephrine HCl
HUMAN COMPOUNDED DRUG
71266-9022
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.1 mg/1 mL
71266-9022-1
Betamethasone Sodium Phosphate
HUMAN COMPOUNDED DRUG
71266-1025
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
BETAMETHASONE SODIUM PHOSPHATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
6 mg/1 mL
71266-1025-2
Betamethasone Sodium Phosphate
HUMAN COMPOUNDED DRUG
71266-1025
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
BETAMETHASONE SODIUM PHOSPHATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
6 mg/1 mL
71266-1025-1
Sodium Citrate
HUMAN COMPOUNDED DRUG
71266-6641
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
TRISODIUM CITRATE DIHYDRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
40 mg/1 mL
71266-6641-1
Phenol in Water
HUMAN COMPOUNDED DRUG
71266-6519
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
PHENOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
60 mg/1 mL
71266-6519-1
NALTREXONE HYDROCHLORIDE
HUMAN COMPOUNDED DRUG
71300-6610
Nubratori Inc.
2024-2
NALTREXONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4.5 mg
71300-6610-9
NALTREXONE HYDROCHLORIDE
HUMAN COMPOUNDED DRUG
71300-6610
Nubratori Inc.
2024-2
NALTREXONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4.5 mg
71300-6610-3
NALTREXONE HYDROCHLORIDE
HUMAN COMPOUNDED DRUG
71300-6647
Nubratori Inc.
2024-2
NALTREXONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4.5 mg
71300-6647-3
NALTREXONE HYDROCHLORIDE
HUMAN COMPOUNDED DRUG
71300-6647
Nubratori Inc.
2024-2
NALTREXONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4.5 mg
71300-6647-9
Baclofen
HUMAN COMPOUNDED DRUG
71300-6635
Nubratori Inc.
2024-2
BACLOFEN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 g
71300-6635-4
071030 FLUCONAZOLE 4% / IBUPROFEN 2% / ITRACONAZOLE 1% / TERBINAFINE HCL 4%
HUMAN COMPOUNDED DRUG
72934-4235
SKNV
2024-2
IBUPROFEN; TERBINAFINE HYDROCHLORIDE; FLUCONAZOLE; ITRACONAZOLE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 g/100 mL; 4 g/100 mL; 4 g/100 mL; 1 g/100 mL
72934-4235-9
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3